Antimicrobial stewardship program, a vital resource for hospitals during the global outbreak of Coronavirus Disease 2019 (COVID-19)
04 September 2020
Healthcare resources are being diverted for the containment and control of COVID-19. During this outbreak, we caution that antibiotic misuse may be increased, especially for respiratory tract infections. With stewardship interventions, duration of antibiotic therapy and length of stay of hospitalized patients can be significantly reduced. Antibiotic stewardship programs should continually engage and educate prescribers to mitigate antibiotic misuse during the COVID-19 pandemic.
Further reading: International Journal of Antimicrobial Agents
Author(s): Yixin Liew et al
Effective Surveillance Healthy Patients
OUR UNDERWRITERS
Unrestricted financial support by:
 |
Antimicrobial Resistance Fighter Coalition |
 |
Evotec |
 |
JSS University |
 |
INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS |
Technology Database
Display your AMR Technology, Product and Service
Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.
